Disc Medicine (IRON) Total Non-Current Liabilities (2020 - 2023)

Disc Medicine (IRON) reported Total Non-Current Liabilities of $16.0 million for Q3 2023, up 994.47% year-over-year from $1.5 million in Q3 2022, and up 39.88% quarter-over-quarter from $11.5 million in Q2 2023.

Disc Medicine (IRON) Total Non-Current Liabilities (2020 - 2023) Analysis & Trends

Disc Medicine (IRON) has 4 years of Total Non-Current Liabilities data on file, last reported at $16.0 million in Q3 2023.

  • Total Non-Current Liabilities for Q3 2023 came in at $16.0 million, up 994.47% year-over-year; the trailing twelve-month figure through Sep 2023 was $16.0 million (up 994.47% YoY), and the FY2022 annual result was $23.6 million, up 76.71% from the prior year.
  • Total Non-Current Liabilities improved to $16.0 million in Q3 2023 per IRON's latest filing, from $11.5 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $29.9 million in Q4 2020 and troughed at -$76000.0 in Q1 2020.
  • A 4-year average of $12.9 million and a median of $13.4 million in 2021 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2021 and 2022: Total Non-Current Liabilities surged 23659.21% in 2021, then slumped 89.77% in 2022.
  • A 4-year view of Total Non-Current Liabilities shows it stood at $29.9 million in 2020, then slumped by 55.33% to $13.4 million in 2021, then soared by 76.71% to $23.6 million in 2022, then tumbled by 32.12% to $16.0 million in 2023.
  • Business Quant data shows IRON's Total Non-Current Liabilities at $16.0 million in Q3 2023, $11.5 million in Q2 2023, and $23.6 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Disc Medicine 2.73 Bn 2.00 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2023 16.02 Mn
Jun 30, 2023 11.46 Mn
Dec 31, 2022 23.61 Mn
Sep 30, 2022 1.46 Mn
Jun 30, 2022 6.44 Mn
Mar 31, 2022 12.67 Mn
Dec 31, 2021 13.36 Mn
Sep 30, 2021 14.31 Mn
Jun 30, 2021 14.39 Mn
Mar 31, 2021 17.91 Mn
Dec 31, 2020 29.90 Mn
Jun 30, 2020 6.55 Mn
Mar 31, 2020 -76,000.00